Balance Labs, Inc.
BLNC
$1.55
-$0.02-1.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 6,835.83% | 114.53% | 57.93% | 116.31% | 233.75% |
| Gross Profit | -6,832.60% | -114.53% | -57.93% | -116.31% | -233.75% |
| SG&A Expenses | 155.33% | 79.50% | 175.42% | 62.82% | 40.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4,732.88% | 104.63% | 88.18% | 95.06% | 133.08% |
| Operating Income | -4,730.67% | -104.63% | -88.18% | -95.06% | -133.08% |
| Income Before Tax | -5,915.58% | -616.78% | -11.54% | -1.56% | -38.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5,915.58% | -616.78% | -11.54% | -1.56% | -38.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5,915.58% | -616.78% | -11.54% | -1.56% | -38.39% |
| EBIT | -4,730.67% | -104.63% | -88.18% | -95.06% | -133.08% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -3,673.25% | -608.87% | -11.52% | -1.05% | -38.07% |
| Normalized Basic EPS | -1,964.14% | -787.40% | -38.39% | -39.25% | -46.46% |
| EPS Diluted | -3,686.83% | -558.46% | -14.42% | 10.28% | -21.50% |
| Normalized Diluted EPS | -1,964.14% | -787.40% | -38.39% | -39.25% | -46.46% |
| Average Basic Shares Outstanding | 18.68% | 0.38% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 18.68% | 0.38% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |